Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Rituximab

5

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

1
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Anti-CD20 antibody therapy
4

Publications

Rituximab associated pneumonitis in antineutrophil cytoplasmic antibody-associated vasculitis.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2012 Jan;18;39-41 2012 Jan
Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature.
Respiration; international review of thoracic diseases 2008;76;449-53 2008
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma.
Leukemia & lymphoma 2004 Nov;45;2321-5 2004 Nov

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies